UBX Unity Biotechnology Inc

Unity Biotechnology Inc operates as a biotechnology company. The firm focuses on age-associated diseases such as arthritis, vision loss and cognitive decline.

$0.41
As of 10/04/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/03/2018
Outstanding shares:  140,226,122
Average volume:  1,099,585
Market cap:   $55,403,341
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDT5LR0
Valuation   (See tab for details)
PE ratio:   -5.30
PB ratio:   0.55
PS ratio:   0.00
Return on equity:   -104.83%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy